What exactly is BPC-157 derived from?

BPC-157 is a partial sequence of a protein called Body Protection Compound, which is naturally found in human gastric juice. The "157" refers to its 15-amino-acid sequence. It's synthesized in the lab for research purposes — it's not extracted from human tissue.

Why is BPC-157 studied for so many different tissues?

Because its primary mechanisms — angiogenesis and growth factor signaling — are universal repair processes. Every tissue in your body needs blood vessels and growth factors to heal. That's why researchers have studied BPC-157 in the context of gut, tendon, muscle, bone, and even neurological tissue.

What makes BPC-157 unusual compared to other peptides?

Its stability is remarkable. Most peptides are rapidly degraded in the acidic environment of the stomach, which is why they're typically studied via injection. BPC-157 appears to remain stable in gastric fluid — making sense given that it originates there. This stability is a key reason it attracts so much research interest.

Is BPC-157 a naturally occurring compound?

Yes and no. The parent protein (Body Protection Compound) is naturally present in human gastric juice. BPC-157 is a specific 15-amino-acid fragment of that protein, synthesized in the lab. So while it's based on a natural sequence, the research compound itself is produced synthetically for consistency and purity.

Why is BPC-157 often studied alongside TB-500?

They address complementary aspects of tissue repair. BPC-157 is primarily studied for angiogenesis (building blood supply) and growth factor modulation, while TB-500 is studied for cell migration and actin regulation (helping repair cells physically reach the injury). Together, they cover the "logistics" of healing from multiple angles.

VitaRecovery

BPC-157

Pentadecapeptide from gastric juice.

A 15-amino-acid fragment originally isolated from Body Protection Compound, a protein present in human gastric juice. Studied in in-vitro and animal models for its role in tissue-repair signaling.

Molecular Weight

1,419.53 Da

CAS Number

137525-51-0

Amino Acids

15 residues

Background

Body Protection Compound (BPC) was first identified in human gastric juice. Researchers isolated a stable 15-amino-acid fragment — BPC-157 — and began characterizing it as a candidate mediator of gastric mucosal defense.

Interest expanded when the same peptide appeared in tendon, ligament, muscle, and vascular repair models. Its mechanisms converge on universal tissue-repair processes: angiogenesis, growth factor signaling, and nitric oxide modulation.

BPC-157 is notable for its stability. Most peptides degrade rapidly in the gastric environment; BPC-157 remains active there — a property consistent with its endogenous origin and part of why it remains a frequent subject of published research.

Mechanism

Investigated Mechanisms of Action

Angiogenesis

Studied for its ability to promote vascular growth via VEGF signaling. Vascularization is a rate-limiting step in most tissue-repair processes; investigators have observed the effect across gut, tendon, and muscle models.

NO-System Modulation

Interacts with nitric oxide pathway components implicated in vascular tone and inflammatory regulation. In cell-culture and animal studies, the peptide has been characterized as an NO-system modulator.

Growth-Factor Signaling

Investigated in relation to EGF, FGF, and VEGF pathway components — the signaling axes cells use to proliferate, migrate, and rebuild extracellular structure at injury sites.

Research Areas

Where BPC-157 Has Been Studied

Gastric Protection

Cytoprotection in GI Models

Multiple animal studies characterize BPC-157 as gastroprotective against NSAID-, ethanol-, and stress-induced mucosal injury — consistent with its endogenous origin in gastric juice.

Read the mechanism deep-dive →

Tendon & Ligament

Collagen Organization in Repair Models

In transected Achilles-tendon models, investigators have reported accelerated healing timelines and improved collagen-fiber alignment relative to control — endpoints assessed histologically and biomechanically.

Vascular Repair

Angiogenic Signaling

Studied for its role in vessel formation and re-anastomosis in severed-vessel and ischemia models. Angiogenesis is thought to underlie many of the broader repair phenotypes attributed to the peptide in the literature.

Gut–Brain Axis

Central-Nervous-System Studies

Animal work has examined BPC-157 in the context of dopaminergic and serotonergic pathway modulation. Findings are preliminary — investigators have flagged them as generating hypotheses for further study.

FAQ

Common Questions

BPC-157 is a synthetic 15-residue fragment of Body Protection Compound, a protein present in human gastric juice. The research material is chemically synthesized — it is not extracted from human tissue.

Its investigated mechanisms — angiogenesis, NO-system modulation, and growth-factor signaling — are conserved repair pathways relevant to gut, tendon, ligament, muscle, and vascular tissue.

Its stability in gastric fluid. Most peptides degrade quickly in the acidic GI environment; BPC-157 remains active there — consistent with its endogenous origin.

The parent protein (Body Protection Compound) occurs naturally in gastric juice. The 15-residue fragment used in research is produced synthetically for consistency and analytical purity.

Complementary mechanisms. BPC-157 is studied for angiogenesis and growth-factor signaling; TB-500 is studied for actin regulation and cell migration — together they cover distinct steps in a repair cascade.

BPC-157

Investigated Mechanisms of Action

Angiogenesis

NO-System Modulation

Growth-Factor Signaling

Where BPC-157 Has Been Studied

Cytoprotection in GI Models

Collagen Organization in Repair Models

Angiogenic Signaling

Central-Nervous-System Studies

BPC-157 10mg

From the Library

TB-500 (Thymosin Beta-4)

GHK-Cu (Copper Tripeptide)

Common Questions

Explore More Compounds